661 results on '"Earp, H. Shelton"'
Search Results
2. TAM family kinases as therapeutic targets at the interface of cancer and immunity
3. Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast Cancer
4. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk.
5. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium
6. Discovery and characterization of a functional scFv for CCR2 inhibition via an extracellular loop
7. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis.
8. Discovery of Novel Macrocyclic MERTK/AXL Dual Inhibitors
9. Integrating access to care and tumor patterns by race and age in the Carolina Breast Cancer Study, 2008–2013
10. MERTK Inhibition as a Targeted Novel Cancer Therapy.
11. The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia
12. Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma
13. Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
14. FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036
15. MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer
16. Integrating Biology and Access to Care in Addressing Breast Cancer Disparities: 25 Years’ Research Experience in the Carolina Breast Cancer Study
17. Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications
18. TAM receptor tyrosine kinase MERTK as a therapeutic target in the tumor immune microenvironment in a murine Krasmutant lung cancer model
19. Interaction between androgen receptor and coregulator SLIRP is regulated by Ack1 tyrosine kinase and androgen
20. Tumor-secreted Prosi inhibits macrophage M1 polarization to reduce antitumor immune response
21. Supplemental Figure Legends from TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
22. Supplementary Figures from TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
23. Data from TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
24. Supplemental Materials and Methods from MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
25. Data from MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
26. Supplementary Figure 3 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo
27. Supplementary Figure 2 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo
28. Supplementary Figure 4 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo
29. Supplemental Figure 5 from Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
30. Supplementary Figure 1 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo
31. Data from Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status
32. Figure S4 from MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
33. Data from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo
34. Data from Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
35. Supplemental Figure 2 from Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
36. Supplemental Figure 3 from Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status
37. Supplemental Table 1 from Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status
38. Supplemental Figure 4 from Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
39. Supplemental Figure 1 from Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
40. Supplementary Figure 5 from UNC569, a Novel Small-Molecule Mer Inhibitor with Efficacy against Acute Lymphoblastic Leukemia In Vitro and In Vivo
41. Supplemental Figure 1 from Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status
42. Supplemental Figure 3 from Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
43. Table S1 from MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents
44. Supplemental Figure 7 from Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
45. Supplemental Figure 2 from Small Molecule Inhibition of MERTK Is Efficacious in Non–Small Cell Lung Cancer Models Independent of Driver Oncogene Status
46. Supplemental Figure 6 from Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma
47. Supplementary Data from Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing Assays
48. Supplemental Figures from UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
49. Supplemental Tables from UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
50. Supplementary Figure Legends from Activated Tyrosine Kinase Ack1 Promotes Prostate Tumorigenesis: Role of Ack1 in Polyubiquitination of Tumor Suppressor Wwox
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.